On Wednesday, June 21st, 2017, the FIM announced American Supercross rider Cade Clason is provisionally suspended, effective immediately, pursuant to Article 7.9 of the FIM Anti-doping Code for Adverse Analytical Finding of Amphetamine, a non-specified substance under Section 6 (Stimulants) of the 2017 FIM Prohibited List, in a urine sample collected from him at an in-competition test carried out by the FIM at the 2017 East Rutherford SX.
Per the current WADA Code (World Anti-Doping Agency) that many global sports, including FIM competition, Clason has the right to request and attend the analysis of the B Sample that was collected at the event, and under Article 126.96.36.199 of the FIM Anti-doping Code may also file an appeal of the initial suspension.
Should the second sample result in a positive test and the appeal be denied, Clason faces between a two to four-year suspension, an update in the punishment with the 2015 WADA Code.
During the 2017 Monster Energy Supercross Series, Clason raced with support from the BWR Engines/K1 Speed team and is currently competing in the 2017 Rockstar Energy Drink Motocross Nationals with the Redemption Racing team. He is currently ranked eighth in the MX1 championship standings.
We spoke briefly with Clason on Wednesday morning and discussed the situation. He told us that he has submitted a TUE (Therapeutic Use Exemption) twice in two years; the first form was returned in order to have more information added and no final word of approval came from the FIM after the second one was sent it. It is his understanding that he can still compete in the 2017 Rockstar Energy Drink Motocross Nationals, which is run by the CMRC (Canadian Motosport Racing Corp).
Clason is the second US-based rider to be provisionally suspended through the anti-doping regulations run by WADA, as James Stewart also tested positive for an amphetamine (later revealed to be Adderall as a treatment for Attention Deficit Hyperactivity Disorder) at the 2014 Seattle SX and was issued with a sixteen-month period of ineligability. But these are not the only two riders to receive punishment for WADA infractions: Jake Moss received a four-year ban after a test by ASADA (Australian Sports Anti-doping Authority) found Ostarine, a SARM (selective androgen receptor module) that produces effects similar to anabolic steroids, while his brother Matt received a provisional suspension for a potential violation at the same time.
The full press release from the FIM is posted below…
The Fédération Internationale de Motocyclisme (FIM) has advised US Supercross rider Cade Clason that he is provisionally suspended pursuant to Article 7.9 of the FIM Anti-doping Code. The decision to provisionally suspend Mr Clason was mandatory following the receipt of a report from the WADA accredited laboratory in Cologne indicating an Adverse Analytical Finding of Amphetamine, a non-specified substance under Section 6 (Stimulants) of the 2017 FIM Prohibited List, in a urine sample collected from him at an in-competition test carried out by the FIM at the round of the Monster Energy AMA Supercross, an FIM World Championship held in East Rutherford, New Jersey, USA, on 29 April 2017.
Mr Clason has the right to request and attend the analysis of his B sample.
Mr Cade Clason is provisionally suspended with effect from 21 June 2017. He is therefore barred from participating in any Sports competition until further notice (Art. 10.12 of the FIM Anti-doping Code). Under Article 188.8.131.52 of the FIM Anti-doping Code, Mr. Clason may request lifting of his provisional suspension.
Under the World Anti-Doping Code and the FIM Anti-Doping Code, the FIM is unable to provide any additional information at this time.